Article info

Extended report
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

Authors

  1. Correspondence to Dr Joachim Sieper, Professor of Rheumatology, Charité Medical School, Department of Medicine 1, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin 12200, Germany; joachim.sieper{at}charite.de
View Full Text

Citation

Sieper J, Braun J, Kay J, et al
Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

Publication history

  • Received November 22, 2013
  • Revised January 22, 2014
  • Accepted January 24, 2014
  • First published February 18, 2014.
Online issue publication 
May 08, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.